Dodatne informacije

• Lični podaci

• Datum rođenja: 08.06.1994.
• Mesto rođenja: Niš

• Obrazovanje

• Fakultet: Medicinski Fakultet u Nišu
• Odsek / Grupa / Smer: Farmacija
• Godina diplomiranja: 2018

• Spisak publikacija

• Radovi u časopisima sa IMPACT faktorom:

  Kocic, G., Gajic, M., Tomovic, K., Hadzi-Djokic, J., Anderluh, M., Smelcerovic, A. (2021) Purine adducts as a presumable missing link for aristolochic acid nephropathy-related energy crisis, potential anti-fibrotic prevention and treatment. British Journal of Pharmacology, doi: 10.1111/bph.15618. Online ahead of print.

  
  

  Gajić, M., Džambaski, Z., Ilić, B.S., Kocić, G., Bondžić, B.P., Šmelcerović, A. (2021) Synthesis and analysis of 4-oxothiazolidines as potential dual inhibitors of deoxyribonuclease I and xanthine oxidase. Chemico-Biological Interactions 345, 109536.

  
  

  Ilić, B.S., Gajić, M., Bondžić, B.P., Džambaski, Z., Kocić, G., Šmelcerović, A. (2021) Deoxyribonuclease I inhibitory properties, molecular docking and molecular dynamics simulations of 1‐(pyrrolidin‐2‐yl)propan‐2‐one derivatives. Chemistry and Biodiversity 18, e2000996.

  
  

  Kocic, G., Hadzi-Djokic, J., Cukuranovic-Kokoris, J., Gajic, M., Veljkovic, A., Cukuranović, R., Basic, D., Jovanovic, I., Smelcerovic, A. (2020) Predictive markers for malignant urothelial transformation in Balkan endemic nephropathy: A case–control study. Cancers 12, 2945.

  
  

  Smelcerovic, A., Kocic, G., Gajic, M., Tomovic, K., Djordjevic, V., Stankovic-Djordjevic, D., Anderluh, M. (2020) DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney injury caused by COVID-19 - a therapeutic approach of choice in type 2 diabetic patients? Frontiers in Pharmacology 11, 1185.

• Radovi u ostalim časopisima:

  Gajić, M., Ilić, B.S., Bondžić, B.P., Džambaski, Z., Filipović, A., Kocić, G., Šmelcerović, A. (2021) Xanthine oxidase inhibitory properties of 1,2,3,4-tetrahydroisoquinoline derivatives. Acta Medicae Medianae 60(1), 48-55.